Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.

BACKGROUND Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with an elevated risk of peptic ulcer and upper gastrointestinal hemorrhage, but published reports have lacked information on rates of outpatient disease, have concentrated on the elderly, and have not provided comparisons of rates for specific types of NSAIDs. METHODS We compared incidence rates of peptic ulcer and upper gastrointestinal hemorrhage in 68 028 people younger than 65 years who used diclofenac sodium, naproxen, piroxicam, or sulindac, and who were members of a network of health maintenance organizations. We reviewed automated insurance claims data and medical records to ascertain cases and included conditions treated on an outpatient basis. RESULTS Medical claims data were adequate for crude identification of potential cases, but review of medical records led to rejection of 63% of these, representing either no abnormality or diseases other than peptic ulcer or upper gastrointestinal hemorrhage. Of the total 112 cases, 64 (57%) were treated as outpatients. The crude incidence rate per 1000 person-years in users of any current, recent, or past NSAID was 2.2 and in distant-past users of NSAIDs was 0.75. For diclofenac, naproxen, piroxicam, and sulindac, we found a consistent pattern of decreasing NSAID effects from current to recent to past exposure. The risk of peptic ulcer or upper gastrointestinal hemorrhage was 1.6 cases per 1000 people using NSAIDs. CONCLUSIONS Combining use of automated claims records with review of medical records promotes efficiency while maintaining specificity of case ascertainment. This study, with 57% of cases treated as outpatients, had results consistent with other published reports that were based on hospitalized patients. Within the limits of statistical error, the incidence rates of peptic ulcer and upper gastrointestinal hemorrhage appeared to be similar for the various NSAIDs studied.

[1]  H. Jick,et al.  Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs , 1994, The Lancet.

[2]  L. Abenhaim,et al.  A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. , 1994, Journal of clinical epidemiology.

[3]  A M Walker,et al.  Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort Study , 1992, Epidemiology.

[4]  A. Walker,et al.  The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. , 1992, Archives of internal medicine.

[5]  F. Petersen,et al.  A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists. , 1992, Gastroenterology.

[6]  S. Gabriel,et al.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.

[7]  J. Fries,et al.  Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. , 1991, The American journal of medicine.

[8]  M. Hautekeete,et al.  Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. , 1991, Gut.

[9]  A. Dobson,et al.  NSAIDs and risk of upper gastrointestinal bleeding , 1991, The Lancet.

[10]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[11]  X. Vidal,et al.  Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs , 1991, The Lancet.

[12]  W. Schaffner,et al.  Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.

[13]  J. Elashoff,et al.  Sex and smoking differences in duodenal ulcer mortality. , 1986, American journal of public health.

[14]  H. Frankl,et al.  The incidence of duodenal and gastric ulcers in a large health maintenance organization. , 1985, American journal of public health.

[15]  Kurata Jh,et al.  Epidemiology of peptic ulcer disease. , 1984, Clinics in gastroenterology.

[16]  Jackson Cb,et al.  Physicians' Current Procedural Terminology. , 1973 .

[17]  R L Savage,et al.  Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. , 1993, Arthritis and rheumatism.

[18]  B. Strom,et al.  Use of automated databases for pharmacoepidemiology research. , 1990, Epidemiologic reviews.

[19]  O. Bonnevie,et al.  The incidence of gastric ulcer in Copenhagen county. , 1975, Scandinavian journal of gastroenterology.

[20]  O. Bonnevie.  The incidence of duodenal ulcer in Copenhagen county. , 1975, Scandinavian journal of gastroenterology.

[21]  H. B. Pepinsky,et al.  Observation and inference. , 1954 .